Ascendis Pharma A/SASNDNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank46
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-3.94
↑ 33% vs avg
Percentile
P46
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
-5.88
Historical baseline
PeriodValueYoY Change
TTM-3.94+39.7%
2024-6.53+23.6%
2023-8.55+17.8%
2022-10.40-48.6%
2021-7.00+15.5%
2020-8.28-76.5%
2019-4.69-47.9%
2018-3.17+13.9%
2017-3.68-42.6%
2016-2.58-